Motivation: Integrating different omics profiles is a challenging task, which provides a comprehensive way to understand complex diseases in a multi-view manner. One key for such an integration is to extract intrinsic patterns in concordance with data structures, so as to discover consistent information across various data types even with noise pollution. Thus, we proposed a novel framework called 'pattern fusion analysis' (PFA), which performs automated information alignment and bias correction, to fuse local sample-patterns (e.g. from each data type) into a global samplepattern corresponding to phenotypes (e.g. across most data types). In particular, PFA can identify significant sample-patterns from different omics profiles by optimally adjusting the effects of each data type to the patterns, thereby alleviating the problems to process different platforms and different reliability levels of heterogeneous data. Results: To validate the effectiveness of our method, we first tested PFA on various synthetic datasets, and found that PFA can not only capture the intrinsic sample clustering structures from the multi-omics data in contrast to the state-of-the-art methods, such as iClusterPlus, SNF and moCluster, but also provide an automatic weight-scheme to measure the corresponding contributions by data types or even samples. In addition, the computational results show that PFA can reveal shared and complementary sample-patterns across data types with distinct signal-to-noise ratios in Cancer Cell Line Encyclopedia (CCLE) datasets, and outperforms over other works at identifying clinically distinct cancer subtypes in The Cancer Genome Atlas (TCGA) datasets. Availability and implementation: PFA has been implemented as a Matlab package, which is available at
Introduction
Large amounts of multiple heterogeneous omics data have become widely available with rapid advance of high throughput technologies (Schuster, 2008) . Conventional studies based only on single data types (e.g. gene expression) could account for very limited number of the biological systems or disease complexity (Chari et al., 2010; Gygi et al., 1999; Hamid et al., 2009) . Nowadays, it has been recognized that the distinct types of biological data provide partly dependent views for the whole landscape of complex diseases, and thus integrating multiple data types gives more opportunities to address many biological or medical issues, e.g. coherent genomic alterations (Chen and Zhang, 2016; Kutalik et al., 2008; Zhang et al., 2011 Zhang et al., , 2012 , and cancer heterogeneity (Hamid et al., 2009; Wang et al., 2014) . Therefore, the integrative analysis of various omics data is increasingly becoming an important component of the genomics and bioinformatics (Gevaert, 2008) .
Plenty of integration approaches aim to infer the correlated patterns in multiple-dimensional genomic profiles, named as 'co-modules' or 'molecule-patterns' (Chen and Zhang, 2016; Ghazalpour et al., 2006; Li et al., 2012; Zhang et al., 2012) , shedding light on coherent understanding of biological systems. However, for many cases, very limited molecular features share similar phenotypes across data types, thus resulting in unreliable identification of prognostic distinct subtypes. Besides, diverse data sources could not provide identical information to uncover 'sample-patterns' (e.g. cancer heterogeneity) due to systematic noises or scale differences. Thus, the confident signals supported by a handful of data types (i.e. complementary sample-patterns) were often missing, and the shared noises could be strengthened. To address these issues, several integration approaches were developed in recent years. For example, iClusterPlus (Mo et al., 2013) , an enhanced method derived from iCluster (Shen et al., 2010) , considers different variable types using a couple of generalized linear models. However, iClusterPlus is based on Gaussian assumption, which could not discover the patterns when data is too heterogeneous on signal distributions. Another popular method called as similarity network fusion (SNF), was proposed by Wang et al. (Wang et al., 2014) , to construct sample networks from each data type, and then fuse them into one weighted sample-similarity network. In their work, SNF treated all available data types equally, which may lead to diluting signals and make a false 'fusion' due to different platforms or reliability levels of data types. Later, Meng et al. presented moCluster (Meng et al., 2015) , which is based on PCA. But, simple PCA could not deal with low signal-to-noise data, resulting in the unstable performance of moCluster. Hence, a data-driven method, which not only can exploit the data structures but also has the ability of the automated information fusion and bias correction, was still lacking.
To overcome the challenges above, we proposed Pattern Fusion Analysis (PFA), a novel computational framework that can identify the integrated 'sample-patterns' across heterogeneous genomic profiles, based on an adaptive optimization strategy. In particular, PFA can align local sample-patterns derived from each data type into a global sample-pattern to characterize phenotypes. In such a way, PFA is capable to capture biologically meaningful sample-pattern in a low-dimensional feature space as well as to quantitatively evaluate how informative each data type or even a sample is to support this global sample-pattern. To validate the effectiveness of PFA, we have tested PFA on several synthetic datasets, and found that PFA with great robustness, could accurately obtain the intrinsic sample-wide patterns compared to the established integration methods (such as iClusterPlus, SNF and moCluster). Furthermore, we have applied PFA to CCLE (The Cancer Cell Line Encyclopedia) (Barretina et al., 2012 ) datasets and three multi-level cancer datasets in TCGA (The Cancer Genome Atlas) (Cancer Genome Atlas Research, 2013) . PFA successfully identified distinct subgroups of cells or patients with biological or clinical importance, providing novel insights into cancer heterogeneity.
Materials and methods

Method overview
PFA can be summarized with the following two steps, as schematically shown in Figure 1 : (i) Extracting local information including local 'sample-patterns' from each data type by dimension reduction method ( Fig. 1B and C) ; (ii) Capturing the global sample-spectrum or sample-pattern by an adaptive optimization strategy across multiple data types (Fig. 1D) . Here, a sample-pattern is represented by sample-to-sample associations or similarities, and Figure 1B and D was redrawn by modifying the similar figure from that in (Zhang et al., 2012) . Firstly, given k genomic profiles for the same cohort of subjects (e.g. patients or samples), PFA derives genomic features and samplepatterns for every type of data X i i 2 1; . . . ; k; k ! 2 f Þ ð independently through principal component analysis (PCA:
( Fig. 1A and B ). This step is to make dimensionality reduction, i.e. reduce redundancy, by an orthonormal matrix U i , and gain those subsets of features which can represent the local information of each data type (Fig. 1C) .
In the next step, the key essence of PFA is to recognize optimal global sample-spectrum Y by fusing these obtained sample-patterns (e.g. common or complementary patterns) across multiple local sample-spectrums Y 1 ; . . . ; Y k ( Fig. 1C and D 2.3 Capturing global sample-spectrum across data types by adaptive optimal alignment
Next, we align all local patterns above (in different feature spaces from different data types) to a common feature space so as to combine the local patterns across most data types. As motivated by the fact that each layer of biological data would interpret sample-wide pattern with different viewpoints, we further propose an adaptive integration approach to capture signals and remove bias in the local sample-spectrum fusion process. Briefly, the adaption method can be derived by optimizing the fitness function in the following:
where y i j presents the coordinates of sample j in the local sample space identified on data type i; and y j indicates the global coordinates of sample j, which is a d-dimensional vector; and the 'alignment' matrix L i is used to construct the unified affine space in order to align the i th local information to the global information; and b is used for matrix Y centralization as a d-dimensional vector. w i j is a 
2. Doing the eigenvalue decomposition of the matrix 
Actually, the function (5) has no unique optimal solution on the matrix Y and cannot ensure the sparsity of the optimal weight W i ði ¼ 1; . . . ; kÞ. Thus, it is necessary to add the orthogonality constraints of the matrix Y and L 2 -norm of the 'correction matrix' W. Finally, by adding all those soft constraints, the extended objective function of PFA with variables Y and W is defined as follows:
s:t:
where
and k is a tuning parameter, used to balance the solution accuracy of matrix Y and the sparsity of estimated weight W. To solve the optimization problem (9), we alternatively minimize the objective function with respect to Y and W.
When fixing W, we can update Y by computing the eigenvectors of the matrix U with eqn. (6). And the optimal Y is shown by formula:
where the matrix W d is formed by the d eigenvectors of U, corresponding to the 2 nd to the (d þ 1) th smallest eigenvalues, and
Then fixing Y, the optimal W is the solution of the following problem:
. Assume that D are sorted in increasing order, i.e.
Then, the optimal solution of the problem (11) is given as follows based on Theorem 2 in Supplementary Information:
From function (12), we can see that the optimal W has only N nonzero entries and can be calculated analytically once we know the optimal N. In practice, to find the optimal N, a simple approach is to check the case from
we determine the value of N, as shown in Algorithm 2.
Based on function (9) and Algorithm 2, the global samplespectrum can be captured using another algorithm named Algorithm 3.
Iterative updating process and clustering method
The procedure from local sample-spectrums extracted by Algorithm 1 based on each data type, to the global sample-spectrum Algorithm 2 Algorithm to calculate optimal W Input: D (in ascending order) and k Output: optimal weight matrix W aggregating across genomic data types identified by Algorithm 3, is presented in a summarized Algorithm 4. Such process has the advantage to reduce bias and obtain an optimal global sample-pattern.
Furthermore, the global sample-spectrum, i.e. the sample coordinates in the certain space, can be clustered by any traditional clustering algorithms. In this paper, we adopted k-means clustering (Ding and He, 2004) as a downstream analysis of the main PFA.
Results
Evaluation of PFA on simulated examples
To demonstrate the ability of PFA on subgroup identification by fusing the sample-patterns from various data types, numerical experiments were conducted based on the simulated datasets (Meng et al., 2016) , with comparison to several existing methods as iClusterPlus, SNF and moCluster. In addition, the efficiency of our adaptive optimization strategy of PFA was also evaluated in the simulated examples.
Synthetic data
Two categories of numeric datasets were generated for a systematic evaluation against the ranged bias. Each contains 3 data layers (or types) and 400 samples, created from real genomic profiles with biological variation levels under the pre-determined sample clusters by Singular Value Decomposition (SVD), as described in Supplementary Information. The data of relevant layers come from the corresponding GSE51557 (Conway et al., 2015) , GSE73002 (Shimomura et al., 2016) and GSE10645 (Nakagawa et al., 2008) (i.e. DNA methylation data, miRNA expression and RNA expression, respectively). We called the 'good-condition' numeric example as simData1 ( Supplementary Fig. S1 ) where all the layers of data could provide partial but effective information to describe the global sample-spectrum (e.g. common or complementary sample-patterns), and named the 'bad-condition' numeric example as simData2 where signals in one of the three layers are substantially insufficient (e.g. Layer II in Fig. 2A ), providing little information on the integrated sample-pattern (see Supplementary Information) . Briefly, the 400 samples in simData1 and simData2 were randomly selected from the above real genomics data, while four sample clusters (namely, 1-100, 101-200, 201-300, 301-400) are distinctly distributed, where 1-300 are designed with complementary sample-patterns and 301-400 are shared across the given numeric data layers (see Supplementary Information). Note that the global sample-pattern cannot be recovered by any single data layer in the two datasets ( Fig. 2A and Supplementary Fig. S1A ).
In addition, another simulated dataset (i.e. simData3) was generated to test the power of the adaptive optimization strategy, an important scheme in our method. It contains 6 data layers and 300 samples, randomly generated from real biological dataset GSE10645. Across the six data layers, 3 sample clusters (i.e. 1-100, 101-200, 201-300) were established in Supplementary Fig. S2 . In particular, the layer I presents a clear separation, while from layer I to layer VI, the noise levels become progressively strong, making it increasingly difficult to discover such pattern structure (see Supplementary Information).
Evaluation and comparison on sample-cluster identification
We applied PFA and the other methods to the first two simulated datasets (i.e. simData1 and simData2) for evaluation and comparison on sample-pattern discovery. In order to determine the robustness of these methods in a consistent manner, the datasets were both repeated 500 times under different systematic conditions (i.e. low:0% extra noises; moderate: 10% extra noises; high: 30% extra noises), respectively. And the performance of each algorithm was measured by a criterion, defined as Accuracy Score¼ (number of correct cluster assignments/total number of cluster assignments). Overall, according to all the results, PFA always succeeded to piece local information together, distinguishing the pre-designed 4 clusters. In addition, the PFA model outperformed over other approaches in terms of both accuracy and consistency across distinct noise strength (Fig. 2B) . iClusterPlus also performed stably in the 'good-condition' and 'bad-condition' examples, probably because of its Monte Carlo sampling procedure (Mo et al., 2013) , but when the added noise was moderate or high, the precision of iClusterPlus was always low (around 60%). In the 'good-condition', SNF could better capture the sample-pattern due to its nonlinearity (Wang et al., 2014) , but nevertheless SNF fused more noises in simData2 subgroup identification when the signal of a local pattern became weaker in 'bad-condition', thus pulling down its performance (Fig.  2B, Supplementary Fig. S1B ). It is worth to note that moCluster performed the worst against noise and in identifying complicated data structures among these methods (Fig. 2B) . As indicated in Table 1 for the summarized simulation results, the performance of our PFA and the previous SNF was similar when all the data layers could provide effective information, while our approach achieved obvious superior data adaptability to SNF and others when signal-to-noise ratio of any used data type was disturbed (i.e. Layer II in simData2). Under all conditions, our method indeed has stable and better ability to identify global sample spectrum than the traditional approaches.
Evaluation of adaptive optimization strategy of PFA
We further demonstrate the effectiveness of our PFA process, i.e. the adaptive optimization strategy, which helps to reduce the side effect of 'dirty' data types based on inherent characteristics of data. In the integration results, weight measurements (i.e. 'correction' matrix) will quantitatively evaluate the contribution by each data type (or sample) to the global sample-pattern identification. Here, we used simData3 to test the utility of our novel strategy and took silhouette score (Rousseeuw, 1987) , which measures cluster coherence, as a signal strength indicator in each data layer. PFA was applied to the numeric examples for 1000 times, and then the association between our estimated weight and signal strength was shown in Figure 3 . The falling trend across varying data layers is consistent with the evaluation criterion as expected (Spearman correlation test, P-value < 1:0 Â 10 À15 ). In other words, enhanced to traditional PCA, PFA is capable to recognize data of high signal-to-noise ratios adaptively and automatically eliminate the effects of noisy data types (or noisy samples) in the integration process. Therefore, such adaptive optimization enables our method to perform robust and powerful in diverse situations as shown in Figure 2 .
Study on CCLE data
We next applied PFA to CCLE datasets (Barretina et al., 2012) , where two data types, i.e. matched gene expression data of Affymetrix-HT-HG-U133V2 array and copy number variation (CNV) profiles of Affymetrix-GW-SNP6 array for 415 cell lines, were obtained, representing 11 different tumor types (intra-group cell line number > 25; Supplementary Table S1 ). When multiple transcript probes point to the same gene, their average value is kept for this gene. And the tissue-specific genes were downloaded from The Human Protein Atlas (Uhlen et al., 2015) and PaGenBase (Pan et al., 2013) , while tumor associated genes were collected from GeneCards (Safran et al., 2010) . Since upper aerodigestive tract (UADT) contains a number of organs, e.g. tongue, trachea and esophagus, their gene union was regarded as UADT tissue-specific gene set, in the following analysis. One-sided t-test was used to identify the over-expressed tissue-specific genes between certain tumor cell lines and the rest, and two-sided t-test was adopted for identifying the differential expressed/CNV tumor-specific genes. FDR correction was implemented in the process. A high proportion of over-or differential-expressed genes indicates a high score for preserving tissue-or tumor-specific characteristics. At first, we carried out PFA algorithm to figure out histological tumor patterns with CCLE data. Although the clusters identified by PFA could fit 11 original groups ( Supplementary Fig. S3A ), the pattern structures between the cell lines seem to have other explanations (clustering overlap ratio: 71%). From Figure 4C and Supplementary Fig. S4 , we noted that tumor types in terms of expression data or CNV profiles show different capacities for preserving tissue-and tumor-specific characteristics, which would challenge the histological separations and suggest molecular-based samplepatterns. Thus, derived from data itself, a 9-cluster sample-pattern ( Supplementary Fig. S3B ) reassigns cell lines as an optimal solution by the current model, and a similar result was obtained in Mo's work (Mo et al., 2013) . Different from their analysis, we carefully illustrated sample-patterns based on single and combined data types, and also assessed the clusters using tissue/tumor similarity measurement (Ravasi et al., 2010; Sandberg and Ernberg, 2005) .
As expected, the molecular-based sample-spectrum identified by PFA is a spatial picture fusing different side views from single data types (Fig. 4A) . For example, among the 'clear' integrative clusters, the gene expression and CNV data can both support the separation of c2 (short for cluster2), c3, c5 and c9 (i.e. shared patterns across multiple data types). In addition, the pattern structures of c1 and c4 are strongly supported by the gene expression profiles, which make the final fused patterns similar to expression-based subgroups (i.e. weakly complementary patterns across multiple data types). Moreover, our model even did a relative fuzzy assignment of c6, c7 and c8 due to the weak expression signals and almost blank CNV information (i.e. strongly complementary patterns across multiple data types), also implying PFA as an effective data-driven method. Given the overall partitions, we investigated the associations between tumor types and the identified cell clusters, calculating tumorcluster enrichment ratios, e.g. all the cell lines of acute myelocytic leukemia (AML) are assigned to c2, thus AML-c2 enrichment ratio is 1.0 and AML-ci (i ¼ 1,3,4,. . .,9) ratios all equal to 0.0. Hence, we could define an Identity Score (IS), which uses entropy to quantify the extent to heterogeneity between cell lines originating from the same tumor type (Fig. 4B) . According to the definition, a minimal IS ¼ 0 would be reported for cell lines within the tumor concentrated only in a single cluster, while a maximal IS ffi1 would be reported for cell lines uniformly separated into 9 clusters. And we found that the IS distribution was negatively correlated with maintenance of tissue-specific characteristics at transcription level (Spearman correlation -0.65), as well as more in concordance with tumor-specific gene proportions in terms of expressions and CNV profiles (Spearman correlation -0.85 and -0.85). It means that when cell lines hold more tissue-or tumor-specific characteristics, they prefer to be grouped together and the IS of this tumor type achieves low; on the contrary, when IS is high, it indicates the cell lines would lose their tissue or tumor identity so that the molecular aberrations of great variation underlie different clusters or subgroups. For example, AML and multiple myeloma (M. myeloma) cell lines (IS: 0.0 and 0.07, respectively) keep relatively high proportions of tissue-and tumor-specific gene expression characteristics (Fig. 4C) , and are correctly separated, while pancreatic, LUSC (lung squamous cell carcinoma) and LUAD (lung adenocarcinoma) cell lines (IS: 0.70, 0.64 and 0.61, correspondingly) show great tumor heterogeneity, which agreed with previous findings using CCLE datasets (Barretina et al., 2012; Mo et al., 2013) .
Next, we investigated the associated characteristics across the composited tumor types within the same fuzzy integrated cluster.
For instance, the two main tumor types in c9 are melanoma (IS: 0.17) and central nervous system (CNS) (IS: 0.34), for which 90% melanoma and 74% CNS cell lines are clustered together in c9. Though melanoma cell lines lose many tissue-specific characteristics, they maintain tumor-specific expressions and CNV profiles well (Fig. 4C, Supplementary Fig. S4 ), to keep tumor homogeneity. Additionally, these melanoma tumor characteristics prefer to be shared with intra-group CNS cell lines (Fisher's exact test, P-value < 2 Â 10 À16 and ¼ 0.0087 for expression and CNV, respectively), other than inter-group CNS cell lines (P-value ¼ 0.00032 and 0.028), indicating cell lines within c9 more similar at molecular levels. While, another cluster of c5 groups 96% UADT squamous carcinoma (IS: 0.07) and 30% LUSC cell lines together in an alternative way. UADT cell lines have dys-regulation of 37% of tumor-specific genes, but few overlap with c5-LUSC cell lines (Fisher's exact test, P-value ¼ 0.16). Actually, these c5-LUSC cell lines seem to 'gain' those UADT tissue-specific characteristics. Of 262 UADT tissuespecific genes (genes shared with lung tissue removed), 24, 138, 194, 138 were differentially expressed (FDR < 0.05) between c5-UADT cell lines and c5-LUSC, LUAD, SCLC (small cell lung carcinoma), other LUSC ones, respectively. Besides, these differential expressed genes are highly overlapped among the three control groups ( Supplementary Fig. S5A ). All these results indicate that c5-LUSC may overcome the tissue 'barrier' and become UADT-like (P-value ¼ 0.0045), which was previously implicated in clinical studies (Delahaye-Sourdeix et al., 2015; Hsieh et al., 1997) . In addition, through the top 5 over-expressed UADT tissue-specific gene panel ( Supplementary Fig. S5B ), the c5-LUSC subgroup exactly corresponds to a basal-S100A8 subtype identified on expression data (Wilkerson et al., 2010) with important diagnostic implications. Not coincidentally, such shared molecular patterns (i.e. 9 clusters) between tumors are also observed and verified in Mo's work (Mo et al., 2013) . Hence, we can see the pan-cancer integrated patterns would summarize molecular aberrations across tissue origins or tumor types and provide new insights on clinical strategies (Weinstein et al., 2013) . Besides, these results also support that PFA indeed has superior ability to reveal sample-patterns (e.g. shared and complementary patterns) across data types of distinct signal-to-noise ratios.
Study on TCGA data
To demonstrate the effectiveness of PFA for addressing clinical issues (i.e. prognostic prediction), we also applied PFA to the omics data of three cancer sites from the TCGA Data Portal (accessed March, 2016) with most samples in high-risk on survival: kidney renal clear cell carcinoma (KIRC), lung squamous cell carcinoma (LUSC) and glioblastoma multiforme (GBM). For each individual of these tumor types, its corresponding gene expression, miRNA expression and DNA methylation profiles were arranged. To get the largest sample size for analysis, we used different platforms for these cancer types: gene expression data of Illumina-Hiseq-RNASeq platform in KIRC, of Illumina-HiSeq-RNASeqV2 platform in LUSC and of Affymetrix-HT-HG-U133A in GBM; miRNA expression data of Illumina-GA-miRNAseq platform in KIRC and LUSC, of AgilentmiRNA-8X15K platform in GBM; DNA methylation data of Illumina-HumanMethylation-27 platform in KIRC, LUSC and GBM. And publicly available clinical information for each patient was also downloaded, especially including the overall survival data.
Then we identified and removed those samples if these samples have more than 20% missing data in any data type. In addition, those features with 20% or more missing values across patients were (i¼1,2,. . .,9) and tumor j (j¼1,2,. . .,11), respectively. Tumor Identity Score is computed as ISj ¼
, where Q j is the fractional separation of tumor type j under a null model assuming uniform separation across clusters. (C) Tumor types in terms of gene expression profiles show different capacities for preserving tumor-and tissue-specific characteristics. The proportion of up-regulated genes to tissue-specific genes measures the tissue-specific characteristics preservation, and the proportion of differentialexpressed genes to tumor associated genes measures the tumor-specific characteristics preservation abandoned. And the average values among other samples were imputed for remaining missing data. After such a pre-process, the three datasets with 122 patients in KIRC, 107 in LUSC and 215 in GBM were prepared for our PFA method. The complex contexts, varying in data platforms and sample sizes as heterogeneity, would provide strong evidences to determine whether PFA could identify clinically relevant subtypes (Zang et al., 2016) .
After implementing PFA, 2 clusters (i.e. subtypes) for KIRC, 3 clusters for LUSC, and 3 clusters for GBM can be assigned according to the silhouette implications ( Supplementary Fig. S6 ). Together with the available clinical index of each patient, a subgroup-based Cox log-rank model was built and it evaluated the survival risks between the identified subtypes from KIRC (P-value ¼ 2:2 Â 10 À3 ), LUSC (P-value ¼ 7:3 Â 10 À4 ) and GBM (P-value ¼ 1:6 Â 10 À6 ) respectively, as the survival curves shown in Figure 5A and Supplementary Fig. S7 . Given that the mentioned methods achieved the same number of clusters, the different performance across cancers (Table 2) indicated that PFA could capture the inherent characteristics of samples and has the best clinical prognosis efficiency comparing with iClusterPlus, SNF and moCluster. We next analyzed the identified KIRC subtypes and highlighted their clinical differences as further validations. Firstly, we found that the obvious difference of survival time between the two groups ( Fig.  5A ) highly correlated with tumor metastatic status (Fisher's exact test, P-value ¼ 3:4 Â 10 À4 ), implying the separation created by PFA is biologically significant. In addition to KIRC associated features ( Supplementary Figs. S8-S10 ), we performed two-sample one-sided t-test to identify differential mRNA expressions, DNA methylations and miRNA expressions (FDR < 0.05). A set of 5 genes differentially expressed and their anti-methylations were found to be (negatively) associated with such expression pattern (Zeng and Li, 2010) , revealing methylation-induced gene expressions (Fig. 5B) . In this case, the patients in subtype 2 corresponding to CD44, ANXA2 overexpression, showed a shorter survival time, consistent with previous findings (Li et al., 2015b; Yang et al., 2015) . Besides, has-mir-21, ever demonstrated important roles in KIRC regulation and metabolism (Cancer Genome Atlas Research, 2013), also predicts the poor prognosis when up-regulated (Fig. 5C ). In addition, our analysis revealed under-expression of has-mir-126 and has-mir-139 in metastatic patients with poor clinical outcomes (Li et al., 2015a) , supporting the identified KIRC classification scheme as well. These validated or potential concordant events shared between integrated subtypes would clarify tumor biology and reveal functional associations based on multiple data types simultaneously.
Discussion
The distinct types of biological data could provide different viewpoints for understanding the complex biological phenomena (Chen and Zhang, 2016; Ghazalpour et al., 2006; Kutalik et al., 2008; Li et al., 2012; Zhang et al., 2012) . In the recent decade, many integration approaches for multi-omics data were proposed to identify 'comodules' or 'molecule-patterns', including the 'ping-pong' algorithm (Kutalik et al., 2008) , non-negative matrix factorization (NMF) methods (Zhang et al., 2012) and generalized regression methods (Mo et al., 2013) . However, for many cases, only very limited molecular features or molecule-patterns, underlying the overall samplespectrum, share similar phenotypes across data types, and thus making the identified subtypes of the clinic samples unreliable. Hence, to overcome such problems, an integration method with automated information fusion and bias correction is demanded.
In this paper, we proposed a data-driven integration approach named as PFA. The key concept of our method is that the sample cluster-/subtype-structure is actually determined, but we look into it from different perspectives (e.g. gene expression, DNA methylation, etc.). Thus, the process to develop a comprehensive perspective could be summarized as adaptive data alignment, including automated information fusion and bias correction in accordance with data inherent structures. Through this scheme ( Supplementary Fig. S12A ), PFA performs to identify global sample-spectrum with biologically functional interpretations, and its brief summary is as follows. Firstly, PFA obtains the local sample-patterns from all data types by PCA. Then, it aligns those local sample-patterns to a common feature space and synthesizes the global sample-pattern across most data types. During this process, the contributions by each data type (or individual sample) on the global sample-spectrum would be quantitatively measured and the effects of bias or systematic noises would be iteratively decreased to better fit the data. The repeated correction will end when it reaches convergence. After the adaptive optimal alignment, the combinatorial sample-pattern could represent comprehensive characterization, which would be more close to inherent relations in data. To demonstrate the benefits of our adaptive optimization strategy, we carried out both synthetic examples and real cancer datasets, as well as made a comparison to the state-of-the-art integration methods (i.e. iClusterPlus, SNF and moCluster) (Supplementary Fig. S12B ). As expected, we found that our estimated weight was identical to signal strength measured by an independent criterion (i.e. silhouette score). In the simulation studies ( Supplementary Fig. S11 ), PFA effectively recovered the designed subgroups and outperformed over the relevant methods, in terms of clustering accuracy and robustness. Besides, the sample-patterns identified by PFA in CCLE datasets and TCGA datasets were proven to be highly correlated with the clinical data, indicating the effectiveness of PFA in deriving biologically meaningful information. Opposed to analyzing individual datasets separately, PFA provides a way to objectively fuse multi-omics data, and it also reveals molecule-patterns across different layers of data, i.e. methylation-induced genes for KIRC, which support the identified sample-spectrum sharing phenotypes. Moreover, the quantitative assessment would provide a highlighted biological insight into precision medicine, or the approach could be generally applied to other subjects requiring various data sources' integration.
Although our adaptive alignment can best fit the data structures, it still may make a 'weak' or 'wrong' fusion when the biases consistently exist in the majority of data types. For example, in the LUSC subtype identification, the survival curves between two clusters are very close (Supplementary Fig. S7A) , and all the other methods mentioned in the contexts cannot provide a clear prognostic separation under the same condition. This is probably because those data types (i.e. expression, miRNA and methylation) are not sufficient to distinguish some sub-cohorts and more data types relevant to LUSC heterogeneity (e.g. somatic mutation or CNV) or clinical covariates (e.g. tumor size, metastatic status, etc.) should be considered. And our method currently has not particularly dealt with discrete data types, e.g. somatic mutation, which should be improved as well in the future work. We also believe the adaptive optimal PFA could be extended to uncover more sophisticated biological features by integrating multi-layer heterogeneous data in time course (Chen et al., 2012) .
